Delivery Order SPE2DB22D2007-SPE2DB25FJ4QS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a hormone treatment medication, valued at $7,627.72 under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,140.26 firm fixed-price delivery order is for the supply of medroxyprogesterone 150 mg/ml, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $12,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a one-day contract spanning August 24-25, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified....
- This is a $1,562.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,212,074 milliliters of medroxyprogesterone 150 mg/ml, a medication, with an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.38 contract is for the delivery of 4,568,119,737 milliliters of the medication Medroxyprogesterone 150 mg/ml. The award has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a ceiling value of $2,309.68 and was awarded on September 20, 2022, with a completion date of September 21, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,772.99 fixed-price delivery order contract is for the supply of Medroxyprogesterone, a pharmaceutical drug. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,584.08 firm-fixed-price delivery order is for the supply of 4566764107 MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through December 20, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a firm fixed price, with a ceiling value of $3,016.81, and a performance period through July 3, 2025. The contract is not set aside and was awarded on July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,945.38 to AmerisourceBergen Drug Corp for Medroxyprogesterone, a synthetic progestin commonly used in hormone therapy and contraceptive applications. Issued on August 20, 2025, with an ultimate completion date of August 21, 2025, this firm fixed-price contract represents a non-competitive, non-set-aside award. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4QSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,839.57 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/ml. This competitive award, issued on September 4, 2025, carries a firm fixed price structure with performance completion targeted for September 5, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, generic drugs, vaccines, and other critical medical commodities. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, leverages this expansive contract vehicle to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 9/4/25 |